How have treatments for hepatocellular carcinoma improved?

Researchers at the Hospital Clínic-IDIBAPS and the University of Barcelona have published a review article in the journal Nature Cancer in which they describe the molecular alterations observed in the evolution of hepatocellular carcinoma, the most common type of liver cancer, and propose a sequencing strategy for systemic treatment, incorporating all the therapies approved to date.  

Roser Pinyol and Josep M. Llovet, co-authors (Photo: Francisco Avia)

Related contents